# A Strain Change Study for SARS-CoV-2 rS Vaccines

> **NCT06409663** · PHASE3 · COMPLETED · sponsor: **Novavax** · enrollment: 60 (actual)

## Conditions studied

- Severe Acute Respiratory Syndrome Coronavirus 2 Infection

## Interventions

- **BIOLOGICAL:** NVX-CoV2705 Vaccine

## Key facts

- **NCT ID:** NCT06409663
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-14
- **Primary completion:** 2024-10-15
- **Final completion:** 2025-04-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409663, "A Strain Change Study for SARS-CoV-2 rS Vaccines". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06409663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*